The company launched in November 2024 with a specific mission: provide physician-formulated nutritional support for people using GLP-1 receptor agonist medications for weight management
Indias drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has not issued clear guidance on whether skin doctors can prescribe these drugs at all
Brain Res 1623:166173 Holfeld J, Tepekoylu C, Blunder S, Lobenwein D, Kirchmair E, Dietl M, Kozaryn R, Lener D, Theurl M, Paulus P et al (2014) Low energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylation
semaglutide 1.0 mg (58 AEs) compared with semaglutide 0.5 mg (44 AEs) and placebo (42 AEs) (Table 3)
Tozuleristide is currently in clinical development focused on pediatric central nervous system tumors